
Ovulation Testing Kits Market Report 2026
Global Outlook – By Product Type (Urine-Based, Saliva-Based, Salivary Ferning), By Distribution Channel (Pharmacies And Drugstores, Hypermarkets And Supermarkets, E-Commerce, Other Distribution Channels), By End User (Hospitals, Clinics, Diagnostic Centers, Fertility Centers, Home Care Settings, Other End Uses) – Market Size, Trends, Strategies, and Forecast to 2035
Ovulation Testing Kits Market Overview
• Ovulation Testing Kits market size has reached to $3.32 billion in 2025 • Expected to grow to $5.19 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Declining Fertility Rates Globally Drive Growth In Ovulation Testing Kits Market • Market Trend: Comprehensive At-Home Multi Hormone Fertility Monitoring Solution • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Ovulation Testing Kits Market?
Ovulation testing kits are diagnostic tools designed to help individuals determine the most fertile days of the menstrual cycle by detecting the surge in luteinizing hormone (LH) that precedes ovulation. These kits are commonly used by those trying to conceive to identify the optimal time for intercourse to increase the likelihood of pregnancy. These kits are valuable tools for family planning, offering a non-invasive and straightforward method to understand better and utilize the body's natural fertility signals. The main product types of ovulation testing kits are urine-based, saliva-based, and salivary ferning. Urine-based refers to ovulation testing kits that detect hormonal changes in urine to predict ovulation. The various distribution channels are pharmacies and drugstores, hypermarkets and supermarkets, e-commerce, and others. These are used by various end users including hospitals, clinics, diagnostic centers, fertility centers, home care settings, and others.
What Is The Ovulation Testing Kits Market Size and Share 2026?
The ovulation testing kits market size has grown rapidly in recent years. It will grow from $3.32 billion in 2025 to $3.66 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to growing awareness of fertility planning, increasing prevalence of delayed pregnancies, expansion of home diagnostic product availability, rising adoption of self-testing healthcare devices, improvements in hormone detection technologies.What Is The Ovulation Testing Kits Market Growth Forecast?
The ovulation testing kits market size is expected to see strong growth in the next few years. It will grow to $5.19 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for connected fertility solutions, rising use of personalized reproductive health tools, expansion of e-commerce distribution for diagnostics, growing focus on women’s health management, increasing adoption of ai-enabled fertility tracking. Major trends in the forecast period include increasing adoption of digital ovulation testing kits, rising demand for home-based fertility monitoring, growing integration of mobile apps with testing kits, expansion of disposable and user-friendly test formats, enhanced focus on accuracy and early fertility detection.Global Ovulation Testing Kits Market Segmentation
1) By Product Type: Urine-Based, Saliva-Based, Salivary Ferning 2) By Distribution Channel: Pharmacies And Drugstores, Hypermarkets And Supermarkets, E-Commerce, Other Distribution Channels 3) By End User: Hospitals, Clinics, Diagnostic Centers, Fertility Centers, Home Care Settings, Other End Uses Subsegments: 1) By Urine-Based: Dipstick Tests, Midstream Tests, Digital Urine Tests 2) By Saliva-Based: Saliva Ovulation Test Strips, Saliva Test Kits with Magnification 3) By Salivary Ferning: Ferning Microscopes, Ferning Test KitsWhat Is The Driver Of The Ovulation Testing Kits Market?
The declining fertility rates are expected to propel the ovulation testing kits market going forward. Fertility rates refer to the number of live births in a population over a specific period, typically expressed as the number of births per 1,000 women of childbearing age (usually aged 15-49) in a year. The declining fertility rate is due to increased education and career opportunities for women, improved access to and use of contraceptives, delayed marriage and childbearing, and high costs of living. Ovulation testing kits serve as valuable tools for individuals or couples facing low fertility rates by offering a non-invasive and accessible method for optimizing the timing of intercourse and improving the chances of conception. For instance, in October 2024, according to the Office for National Statistics, a UK-based governmental organization, in between 2022 and 2023, the total fertility rate (TFR) for England and Wales decreased from an average of 1.49 children per woman over their lifetime to 1.44 the lowest rate on record. Therefore, the declining fertility rates are driving the growth of the ovulation testing kits industry.Key Players In The Global Ovulation Testing Kits Market
Major companies operating in the ovulation testing kits market are Church And Dwight Co Inc, Piramal Enterprises Inc., Meril Diagnostics Pvt Ltd, BIOSYNEX SA, Boditech Med Inc., Mankind Pharma Ltd., Innovita Biological Technology Co. Ltd., Hangzhou Clongene Biotech Co. Ltd., Swiss Precision Diagnostics GmbH, Artron Laboratories Inc., Wondfo Biotech Co. Ltd., AdvaCare Pharma, Proov, Shanghai Chemtron Biotech Co. Ltd., Ava Science Inc., Clinical Guard Ltd., Fairhaven Health LLC, Femometer Ltd., Easy Healthcare Corporation (Premom), Tulip Diagnostics Pvt. Ltd.Global Ovulation Testing Kits Market Trends and Insights
Major companies operating in the ovulation testing kits market are focusing on developing advanced solutions, such as multi-hormone at-home testing systems, to replace traditional single-hormone ovulation test strips. A multi-hormone solution refers to an innovative fertility-monitoring technology that enhances accuracy by measuring several key reproductive hormones simultaneously, providing deeper insights into ovulation timing, cycle health, and overall fertility. For instance, in August 2025, Mira, a US-based women’s health technology company, introduced Ultra4, the first at-home hormone monitors with lab-quality 4-in-1 testing. This solution replaces conventional ovulation kits by measuring four essential fertility hormones, FSH, E3G, LH, and PdG, through a fluorescent-based system that delivers precise, quantitative results. It offers real-time hormone tracking, advanced cycle insights, and new capabilities such as 4D Ovulation Profiling™, which evaluates ovulation timing, strength, and viability. Integrated with the Mira App, the Ultra4™ allows users to visualize hormone patterns, receive personalized fertility predictions, and better understand their reproductive health. The Ultra4 enhances conception planning, improves diagnostic clarity, and empowers users with comprehensive, data-driven fertility monitoring at home.What Are Latest Mergers And Acquisitions In The Ovulation Testing Kits Market?
In December 2023, Biogenes Technologies Sdn Bhd, a Malaysia-based biotechnology company acquired Allen Healthcare Products for an undisclosed amount. With this acquisition, Biogenes Technologies aims to scale up production of diagnostic test kits, enhance its research capabilities, and strengthen its presence in the Southeast Asian market. Allen Healthcare Products is a Malaysia-based rapid test kit company that provides ovulation test kits.Regional Outlook
North America was the largest region in the ovulation testing kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Ovulation Testing Kits Market?
The ovulation testing kits market consists of sales of fertility monitors, digital ovulation predictor kits, combination kits, and ovulation prediction wearables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Ovulation Testing Kits Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $3.66 billion |
| Revenue Forecast In 2035 | $5.19 billion |
| Growth Rate | CAGR of 10.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Distribution Channel, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Church And Dwight Co Inc, Piramal Enterprises Inc., Meril Diagnostics Pvt Ltd, BIOSYNEX SA, Boditech Med Inc., Mankind Pharma Ltd., Innovita Biological Technology Co. Ltd., Hangzhou Clongene Biotech Co. Ltd., Swiss Precision Diagnostics GmbH, Artron Laboratories Inc., Wondfo Biotech Co. Ltd., AdvaCare Pharma, Proov, Shanghai Chemtron Biotech Co. Ltd., Ava Science Inc., Clinical Guard Ltd., Fairhaven Health LLC, Femometer Ltd., Easy Healthcare Corporation (Premom), Tulip Diagnostics Pvt. Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
